← Back to Search

Home Care After Stem Cell Transplantation

N/A

Recruiting

Led By Anthony Sung, MD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness

Age 18-80 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial compares the caregiver strain of those whose loved ones receive standard care vs. home care after a stem cell transplant.

Who is the study for?

This trial is for patients aged 18-80 scheduled for autologous stem cell transplant due to cancer or other illnesses, with a performance score indicating they can care for themselves. They must read/write English and have a caregiver who meets criteria like driving ability. Homes must be suitable for medical care within 90 minutes of Duke.Check my eligibility

What is being tested?

The study compares the strain on caregivers when patients receive home care versus standard care after an autologous hematopoietic stem cell transplant. It aims to determine which setting is better for the well-being of those providing care.See study design

What are the potential side effects?

Since this trial focuses on caregiving post-transplant rather than direct patient treatment, it does not list specific side effects related to medications or interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am scheduled for a stem cell transplant using my own cells.

Select...

I am between 18 and 80 years old.

Select...

I can carry out normal activities without assistance.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Quality of Life in Caregivers (Caregiver Strain Index)

Secondary outcome measures

Disease Free Survival

Measuring Caregiver Burden as recorded in a Time Diary

Measuring Caregiver Fatigue as assessed by the PROMIS-Fatigue

+35 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Home careExperimental Treatment1 Intervention

This is the arm for patients who receive their transplant care in their homes.

Group II: Hospital CareActive Control1 Intervention

Standard of care for stem cell transplant recipients where the aftercare is done in hospital.

Group III: Clinic CareActive Control1 Intervention

Standard of care for stem cell transplant recipients who live at home but receive aftercare in the daily outpatient clinic.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,363 Previous Clinical Trials

3,420,336 Total Patients Enrolled

Anthony Sung, MDPrincipal InvestigatorDuke Health

9 Previous Clinical Trials

552 Total Patients Enrolled

Media Library

home care Clinical Trial Eligibility Overview. Trial Name: NCT03667599 — N/A

Caregiver Strain Index Research Study Groups: Home care, Hospital Care, Clinic Care

Caregiver Strain Index Clinical Trial 2023: home care Highlights & Side Effects. Trial Name: NCT03667599 — N/A

home care 2023 Treatment Timeline for Medical Study. Trial Name: NCT03667599 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment still ongoing for this experiment?

"This research study, which was first unveiled on September 28th 2018, is actively searching for participants. The trial’s details were most recently amended on October 6th 2022."

Answered by AI

How many people are involved in this experiment?

"Affirmative. The information available on clinicaltrials.gov indicates that this trial is presently recruiting participants, and was first published on September 28th 2018 with the last update happening October 6th 2022. This research necessitates 150 volunteers from a single location."

Answered by AI

Is eligibility restricted to persons over 18 years old for this research?

"Potential participants for this trial must fall between 18 and 80 years of age. For those ineligible, there are 4 separate clinical trials for minors and 8 for senior citizens."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

2018. "A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03667599.